On May 28, 2015, a panel from the American Medical Informatics Association (“AMIA”) published an eleven-page “Report of the AMIA EHR 2020 Task Force on the Status and Future Direction of EHRs.”  Recognizing that current problems in EHR use “are complex” and that “[s]olving these problems will require regulatory stability, the development of an acceptable threshold ‘barrier to entry’ into the EHR marketplace, and a supportive national policy,” the report outlines ten “near-term strategies” to address challenges with EHR systems.   

The report’s recommendations cover five areas, which should be “a focus” over the next six to twelve months.  These areas are:

  1. Simplify and speed documentation;
  2. Refocus regulation;
  3. Increase transparency and streamline certification;
  4. Foster innovation; and
  5. “The EHR in 2020 must support person-centered care delivery.”

The recommendations include:

  1. Lessen the data entry burden on clinicians, by allowing relevant information to be entered by, for example, other members of the care team;
  2. Focus regulation on clarifying and simplifying certification procedures and meaningful use regulations, improving data exchange and interoperability, cutting the need for duplicate data entry, and prioritizing patient outcomes;
  3. Improve flexibility and transparency in the EHR certification process to improve usability and safety and foster innovation;
  4. Use “public standards-based application programming interfaces and data standards that will enable EHRs to become more open to innovators, researchers, and patients”; and
  5. Integrate EHRs into the full social context of care.
Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Krysten Rosen Moller Krysten Rosen Moller

Krysten Rosen Moller focuses her practice on representing clients in internal investigations, government investigations, and follow-on civil litigation, with an emphasis on serving clients in the life sciences and healthcare industries.

Krysten assists companies with complex internal and government investigations covering a broad…

Krysten Rosen Moller focuses her practice on representing clients in internal investigations, government investigations, and follow-on civil litigation, with an emphasis on serving clients in the life sciences and healthcare industries.

Krysten assists companies with complex internal and government investigations covering a broad range of issues, including fraud and abuse, advertising and promotion, and bribery and corruption. Krysten has particular experience conducting targeted and efficient internal investigations and representing pharmaceutical and medical device companies against investigations from the Department of Justice or other government regulators. Krysten’s complementary litigation practice focuses on defending life sciences and healthcare companies in related litigation, including cases arising under the False Claims Act and other follow-on litigation arising from government investigations.

Krysten also counsels clients on compliance matters. She regularly represents companies negotiating HHS OIG Corporate Integrity Agreements (CIAs) and advises companies on implementing and operating under CIAs. She has also conducted False Claims Act risk assessments and advised on other fraud and abuse issues.